MCM
IONS icon

M28 Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

M28 Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-126,300
Closed -$4.51M – 14
2023
Q1 		$4.51M Hold
126,300
– – 5.1% 7
2022
Q4 		$4.77M Buy
+126,300
New +$5.31M 4.55% 6

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

M28 Capital Management's IONS Position: Q2 2023 in Review

M28 Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2023, closing a stake of 126,300 shares — an estimated $4.51M sold.

M28 Capital Management first reported a position in IONS in Q4 2022 and held it in 2 quarters. The position peaked at $4.77M in Q4 2022. 304 funds tracked by Wall St. Rank hold IONS as of Q2 2023.

  • M28 Capital Management reported no remaining Ionis Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • M28 Capital Management sold 126,300 Ionis Pharmaceuticals shares in Q2 2023, an estimated $4.51M.
  • M28 Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • M28 Capital Management's Ionis Pharmaceuticals position peaked at $4.77M in Q4 2022.
  • 304 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2023.

Based on M28 Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.